Key Points – JOST Werke posted a record Q1 2026, with sales up 12% to EUR 417 million and adjusted EBIT up 23% to EUR 44 million.
The adjusted EBIT margin improved to 10.6%, bringing the company back into its strategic target range earlier than expected. – Hyva integration and regional strength drove performance, with management saying synergies are ramping up and supporting margin recovery
APAC was the fastest-growing region, while EMEA and the Americas also delivered organic growth despite mixed market conditions. – The balance sheet strengthened after a capital increase, cutting net leverage to 1.75x EBITDA and giving JOST more flexibility for M&A. The company also confirmed its 2026 outlook, expecting single-digit sales growth and faster EBIT growth than revenue. JOST Werke (ETR:JST) reported a record first quarter for 2026, with management citing strong organic growth, early benefits from the Hyva integration and improving profitability despite mixed global market conditions.
Chief Executive Officer Joachim Dürr said the company had a “very strong start” to the year, with quarterly sales reaching EUR 417 million, up 12% from the prior year. Organic sales rose 9%, with all regions and business lines contributing to the increase. Adjusted EBIT climbed 23% to EUR 44 million, also a quarterly record for the group.